|Bid||323.06 x 800|
|Ask||320.37 x 900|
|Day's range||307.49 - 323.97|
|52-week range||258.91 - 428.22|
|Beta (5Y monthly)||0.86|
|PE ratio (TTM)||28.93|
|Earnings date||01 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||26 Nov 1996|
|1y target est||360.08|
MILFORD, Mass., January 24, 2022--U.S. Food and Drug Administration to deploy Waters Empower and NuGenesis software at its medical products testing labs.
Waters (WAT) releases the MS Quan application on the waters_connect informatics software platform to help scientists efficiently screen large number of samples and contaminants.
MILFORD, Mass., January 12, 2022--Waters Corporation (NYSE:WAT) will webcast its Q4 2021 financial results conference call live on Tuesday, February 1st 2022 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters’ investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least February 15th, 2022 at midnight eastern time.